Evonik has published the first edition of the MetAMINO® ATLAS. The report displays the results of 15 performance trials investigating the relative bioavailability of supplementary methionine sources in animal diets.
“For cost-effective purchasing, feed formulation and animal production, precise knowledge about the relative nutritive value of DL-methionine compared with liquid MHA-FA and MHA-Ca is essential,” said Jan-Olaf Barth, head of the Efficient Nutrition product line at Evonik. “With the MetAMINO® ATLAS, we want to support our business partners in making knowledge-based purchase decisions for sustainable and economical livestock operations.”
The trials were conducted in eleven countries on five continents under different climatic, geographic and farming conditions, in experimental settings as well as at commercial farms with broiler chickens, laying hens, swine and aqua species.
“Across all trials and all species, we found that comparable animal performance criteria were achieved when 100 units of MHA-products were replaced with 65 units of MetAMINO®,” said Nils Niedner, product manager MetAMINO®.
The MetAMINO® ATLAS 2022 further includes a selection of the latest scientific articles, conference abstracts and peer-reviewed publications regarding the bio-efficacy of the commercially available methionine forms. Interested parties can access the complete paper via barcode or link.
The report can be downloaded at metamino.evonik.com and myamino.evonik.com.
